Pharmaceuticals, Biotechnology and Life Sciences
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant IONTAS now seeking development partners CAMBRIDGE, England &…
Data have demonstrated vaccine protects against COVID-19 related hospitalization in broad geographic regions, including those with emerging variants1
Decision follows the European Medicines Agency recommendation of the J&J COVID-19 vaccine2
The…
After the US president’s Biden said the US Federal government would buy 100 million doses of the COVID-19 vaccine from Moderna and another 100 million from Pfizer, Moderna today confirmed that it is in discussion with the U.S. government to purchase an additional 100 million doses of the Moderna COVID-19 Vaccine for delivery in the third quarter of 2021.
Reuters news agency referred to the Economic Times as saying Monday that Tata Group’s healthcare venture has reportedly started the first discussions with Moderna Inc for a partnership to launch its COVID-19 vaccine in India.
European Commission’s decision on conditional marketing authorization is expected imminently, after the positive CHMP opinion, which will make BNT162b2 if authorized, the first COVID-19 vaccine available in the European Union.
U.S. FDA has authorized mRNA vaccine against COVID-19 for emergency use as total of 200 million doses ordered by the U.S government to date, with an option to purchase up to an additional 300 million doses, while approximately 20 million doses will be delivered by the end of December 2020.
Moderna has received positive recommendation in support of Emergency Use Authorization of its COVID-19 vaccine candidate in USA.
Total of 160 million doses ordered by the European Commission to date CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology…
– Conference Call Today at 8 a.m. ET – DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced that it expects a…
Moderna has made a deal with the Ministry of Health of Singapore to supply mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support ongoing efforts to secure access to a safe and effective COVID-19 vaccine for the people of Singapore.